Moreover, there is an upregulation of CC-chemokine receptor 7 (CCR7) to improve DC homing to tumor-draining lymph nodes or to tertiary lymphoid structures via lymphatic vessels or blood circulation, where they encounter and activate T cells. The gene discussed is CCR7; the disease is neoplasm.